BriaCell Therapeutics Corp (CVE:BCT) (OTCMKTS:BCTXF) CEO Dr William Willams chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The West Vancouver, British Columbia-based immuno-oncology-focused biotechnology company is developing the first off-the-shelf personalized immunotherapy targeting advanced breast cancer.
BriaCell Therapeutics CEO talks through Incyte collaboration and future plans in 2020
Quick facts: Briacell Therapeutics Corp.
Price: 10.8 CAD
Market Cap: $7.8 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE